LyGenesis

0 followers


LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end-stage liver disease.

Industries

Headquarters

Employees

Links

Org chart

Michael Hufford

Collapse
Paulo A Fontes
Co-founder & Medical Advisor
Jacqueline Jeha, MPH
Director of Clinical Operations and Corporate Development
Jennifer Taylor
Director, Clinical Operations
Paulo Fontes, MD, FACS
Co-founder & Medical Advisor